Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Autologous stem cell transplant (ASCT) is highly effective in selected patients with light chain (AL) amyloidosis. Bortezomib, preceding or following ASCT, improves responses. Satisfactory responses, including at least a partial response, very good partial response (VGPR) with organ response, or com...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood Adv
Huvudupphovsmän: Basset, Marco, Milani, Paolo, Nuvolone, Mario, Benigna, Francesca, Rodigari, Lara, Foli, Andrea, Merlini, Giampaolo, Palladini, Giovanni
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2020
Ämnen:
Clinical Trials and Observations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479942/
https://ncbi.nlm.nih.gov/pubmed/32886751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002219
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk